Requests that the FDA 1. Revise the guidance document(s) and, as necessary, associated regulations under 21 CFR Part 1271 for determining donor eligibility of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including reproductive tissues such as semen, to remove or substantially narrow geographic residency and travel deferrals related to variant Creutzfeldt-Jakob Disease

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Dockets · As of Jun 30, 2026

Requests that the FDA 1. Revise the guidance document(s) and, as necessary, associated regulations under 21 CFR Part 1271 for determining donor eligibility of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including reproductive tissues such as semen, to remove or substantially narrow geographic residency and travel deferrals related to variant Creutzfeldt-Jakob Disease: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

Dockets · As of Jun 30, 2026

DocketsHeld records

The source record

As of Jun 30, 2026; may be out of date.

Docket type: Nonrulemaking
Title: Requests that the FDA 1. Revise the guidance document(s) and, as necessary, associated regulations under 21 CFR Part 1271 for determining donor eligibility of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including reproductive tissues such as semen, to remove or substantially narrow geographic residency and travel deferrals related to variant Creutzfeldt-Jakob Disease
Ingested at: 2026-06-30T05:22:16.053483+00:00

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Requests that the FDA 1. Revise the guidance document(s) and, as necessary, associated regulations under 21 CFR Part 1271 for determining donor eligibility of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including reproductive tissues such as semen, to remove or substantially narrow geographic residency and travel deferrals related to variant Creutzfeldt-Jakob Disease

Dockets	What this connects to	Requests that the FDA 1. Revise the guidance document(s) and, as necessary, associated regulations under 21 CFR Part 1271 for determining donor eligibility of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including reproductive tissues such as semen, to remove or substantially narrow geographic residency and travel deferrals related to variant Creutzfeldt-Jakob Disease has a recorded connection to Dockets.	None